Abstract
Most of the world is currently fighting to limit the impact of the COVID-19 pandemic. Italy, the Western country with most COVID-19 related deaths, was the first to implement drastic containment measures in early March, 2020. Since then most other European countries, the USA, Canada and Australia, have implemented similar restrictions, ranging from school closures, banning of recreational activities and large events, to complete lockdown. Such limitations, and softer promotion of social distancing, may be more effective in one society than in another due to cultural or political differences. It is therefore important to evaluate the effectiveness of these initiatives by analyzing country-specific COVID-19 data. We propose to model COVID-19 dynamics with a SIQR (susceptible – infectious – quarantined – recovered) model, since confirmed positive cases are isolated and do not transmit the disease. We provide an explicit formula that is easily implemented and permits us to fit official COVID-19 data in a series of Western countries. We found excellent agreement with data-driven estimation of the day-of-change in disease dynamics and the dates when official interventions were introduced. Our analysis predicts that for most countries only the more drastic restrictions have reduced virus spreading. Further, we predict that the number of unidentified COVID-19-positive individuals at the beginning of the epidemic is ∼10 times the number of confirmed cases. Our results provide important insight for future planning of non-pharmacological interventions aiming to contain spreading of COVID-19 and similar diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
this work was supported by MIUR (Italian Minister for Education) under the initiative “Departments of Excellence” (Law 232/2016). The funding source had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Public available data only. URLs in the paper.
